Liberum Capital Reaffirms “Buy” Rating for PureTech Health (LON:PRTC)

Share on StockTwits

Liberum Capital reaffirmed their buy rating on shares of PureTech Health (LON:PRTC) in a research report released on Thursday morning, ThisIsMoney.Co.Uk reports.

PRTC has been the subject of a number of other reports. Peel Hunt reaffirmed a buy rating on shares of Costain Group in a research report on Friday, June 28th. Jefferies Financial Group lifted their price objective on shares of PureTech Health from GBX 280 ($3.66) to GBX 340 ($4.44) and gave the stock a buy rating in a research report on Friday, July 5th.

PRTC stock opened at GBX 240 ($3.14) on Thursday. The company has a debt-to-equity ratio of 7.19, a quick ratio of 0.95 and a current ratio of 0.98. The stock’s fifty day moving average is GBX 223.52. PureTech Health has a one year low of GBX 135 ($1.76) and a one year high of GBX 239 ($3.12). The company has a market capitalization of $677.99 million and a PE ratio of -15.00.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.

See Also: Cost of equity and a company’s balance sheet

Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Slack  Earns Neutral Rating from Analysts at Credit Suisse Group
Slack Earns Neutral Rating from Analysts at Credit Suisse Group
Slack  Coverage Initiated by Analysts at Morgan Stanley
Slack Coverage Initiated by Analysts at Morgan Stanley
Solaris Oilfield Infrastructure  Coverage Initiated by Analysts at Citigroup
Solaris Oilfield Infrastructure Coverage Initiated by Analysts at Citigroup
Tanger Factory Outlet Centers  Upgraded to “Hold” at Zacks Investment Research
Tanger Factory Outlet Centers Upgraded to “Hold” at Zacks Investment Research
Sterling Bancorp  Coverage Initiated at B. Riley
Sterling Bancorp Coverage Initiated at B. Riley
Restoration Hardware  Upgraded by ValuEngine to “Hold”
Restoration Hardware Upgraded by ValuEngine to “Hold”


© 2006-2019 Ticker Report